English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  52734223    ???header.onlineuser??? :  368
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

???jsp.browse.items-by-title.jump??? [ ???jsp.browse.general.jump2chinese??? ] [ ???jsp.browse.general.jump2numbers??? ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
???jsp.browse.items-by-title.enter???   

Showing items 333356-333365 of 2348674  (234868 Page(s) Totally)
<< < 33331 33332 33333 33334 33335 33336 33337 33338 33339 33340 > >>
View [10|25|50] records per page

Institution Date Title Author
國立臺灣大學 2016 Dipeptidyl Peptidase-4 Inhibitor Use Is Not Associated With Acute Pancreatitis in High-Risk Type 2 Diabetic Patients: A Nationwide Cohort Study Chang, Chia-Hsuin; Lin, Jou-Wei; Chen, Shu-Ting; Lai, Mei-Shu; Chuang, Lee-Ming; Chang, Yi-Cheng; 賴美淑; 張家勳; 莊立民; 張以承; 林昭維
臺大學術典藏 2019-04-26T09:13:42Z Dipeptidyl Peptidase-4 Inhibitor Use Is Not Associated With Acute Pancreatitis in High-Risk Type 2 Diabetic Patients: A Nationwide Cohort Study Chia-Hsuin Chang;Jou-Wei Lin;Chen, Shu-Ting;Lai, Mei-Shu;Lee-Ming Chuang;Yi-Cheng Chang; CHIA-HSUIN CHANG; JOU-WEI LIN; Chen, Shu-Ting; Lai, Mei-Shu; LEE-MING CHUANG; YI-CHENG CHANG
國立成功大學 2016-09 Dipeptidyl peptidase-4 inhibitor use is not associated with elevated risk of severe joint pain in patients with type 2 diabetes: a population-based cohort study Hou, Wen-Hsuan; Chang, Kai-Cheng; Li, Chung-Yi; Ou, Huang-Tz
國家衛生研究院 2017-03 Dipeptidyl peptidase-4 inhibitors and cardiovascular risks in patients with pre-existing heart failure Ou, SM;Chen, HT;Kuo, SC;Chen, TJ;Shih, CJ;Chen, YT
國家衛生研究院 2021-01-10 Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: A nationwide population-based cohort study in Taiwan Yen, FS;Wei, JCC;Yip, HT;Hwu, CM;Hou, MC;Hsu, CC
中山醫學大學 2021 Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: a nationwide population-based cohort study in Taiwan Yen, FS; Wei, JCC; Yip, HT; Hwu, CM; Hou, MC; Hsu, CC
中國醫藥大學 2014-07-16 Dipeptidyl Peptidase-4 inhibitor類合併使用其他口服降血糖藥物與糖尿病患者發生低血糖症風險之相關性研究 鄭宇傑;Yu-Chieh Cheng
國立臺灣大學 2007 Dipeptidyl Peptidase-Iv Inhibitors: An Evolving Treatment for Type 2 Diabetes from the Incretin Concept 錢瑤珍; 莊立民; CHYAN, YAU-JAN; CHUANG, LEE-MING
中山醫學大學 2020 DIPEPTIDYL-PEPTIDASE 4 INHIBITORS DID NOT IMPROVE RENAL ENDPOINTS IN ADVANCED DIABETIC KIDNEY DISEASE Kornelius, E; Huang, CN; Lo, SC; Wang, YH; Yang, YS
中國醫藥大學 2012-05 Dipeptidyl-peptidase IV inhibitory activity of peptides derived from tuna cooking juice hydrolysates 黃士禮(Huang, Shih-Li);饒家麟(Jao, Chia-Ling);何潔攀(Ho, Kit-Pan);徐國強(Hsu, Kuo-Chiang)*

Showing items 333356-333365 of 2348674  (234868 Page(s) Totally)
<< < 33331 33332 33333 33334 33335 33336 33337 33338 33339 33340 > >>
View [10|25|50] records per page